Cell Receptor Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • (Upcoming)

Cell Receptor General Information


Developer of pharmacological therapies intended to serve in the treatment of cancer and autoimmune diseases. The company specializes in researches on cell proliferation, enabling clients to receive drugs for the treatment of cancer and other autoimmune diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • C/o L&S Trust Services SA
  • Route de Chêne 30A
  • 1208 Geneva
  • Switzerland
+41 077 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell Receptor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) Upcoming Startup
1. Angel (individual) Completed Startup
To view Cell Receptor’s complete valuation and funding history, request access »

Cell Receptor Executive Team (2)

Name Title Board Seat Contact Info
Béatrice Fabricius Founder & Chief Executive Officer
Hans-Åke Fabricius CVO, Scientific Advisor & Product Developer
To view Cell Receptor’s complete executive team members history, request access »